← Back to Clinical Trials
Recruiting NCT04960904

NCT04960904 Study Evaluating the Performance and Safety in the Medium and Long Term of Global D Implant-prosthetic Systems

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04960904
Status Recruiting
Phase
Sponsor Global D
Condition Dental Implants
Study Type OBSERVATIONAL
Enrollment 514 participants
Start Date 2019-11-12
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Dental implant surgery with implants

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 514 participants in total. It began in 2019-11-12 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is set up within the framework of the European Union regulation 2017/745 on medical devices. Its objective is to confirm the performance and safety in the medium and long term of implant-prosthetic systems including Global D dental implants: In-Kone® UNIVERSAL, In-Kone® PRIMO, twinKon®, EVL® S, EVL® K and EVL® C.

Eligibility Criteria

Inclusion Criteria: * Male or female * Major (s) at the time of the implantation * Having needed implant surgery with one or more Global D devices: * between October 1, 2013 - June 30, 2015 for EVL® S, EVL® K and EVL® C, In-Kone® UNIVERSAL and In-Kone® PRIMO implants * between January 1, 2013 - June 30, 2015 for twinKon® implants * Affiliated or benefiting from French Social Security * Not opposing the use of their data * Having carried out his annual follow-up visit at 5, 7/8 and 10 years or any other visit motivated by the removal of the implant during the 10 years Exclusion Criteria: * Patient unable to understand information related to his/her participation in the study * Deceased patient, date of death after the date of implantation

Contact & Investigator

Central Contact

Nathalie TRETOUT

✉ n.tretout@globald.com

📞 0478569700

Principal Investigator

Jean Pierre AXIOTIS, MD

PRINCIPAL INVESTIGATOR

Dental surgeon

Frequently Asked Questions

Who can join the NCT04960904 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Dental Implants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04960904 currently recruiting?

Yes, NCT04960904 is actively recruiting participants. Contact the research team at n.tretout@globald.com for enrollment information.

Where is the NCT04960904 trial being conducted?

This trial is being conducted at Andrézieux-Bouthéon, France, Athens, Greece.

Who is sponsoring the NCT04960904 clinical trial?

NCT04960904 is sponsored by Global D. The principal investigator is Jean Pierre AXIOTIS, MD at Dental surgeon. The trial plans to enroll 514 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology